NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 230 filers reported holding NEKTAR THERAPEUTICS in Q3 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $166,000 | -55.0% | 51,961 | +141.6% | 0.02% | -56.8% |
| Q2 2021 | $369,000 | +73.2% | 21,503 | +67.4% | 0.04% | +8.8% |
| Q3 2020 | $213,000 | +6.0% | 12,847 | +14.0% | 0.03% | -12.8% |
| Q1 2020 | $201,000 | -73.8% | 11,271 | -10.2% | 0.04% | -63.2% |
| Q3 2018 | $766,000 | +273.7% | 12,557 | +266.7% | 0.11% | +194.4% |
| Q4 2017 | $205,000 | -50.2% | 3,424 | -85.7% | 0.04% | -67.3% |
| Q3 2016 | $412,000 | – | 23,948 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 598,400 | $10,083,000 | 3.98% |
| Opus Point Partners Management, LLC | 348,583 | $5,874,000 | 3.88% |
| Camber Capital Management LP | 3,500,000 | $58,975,000 | 3.81% |
| 1492 Capital Management LLC | 180,601 | $3,043,000 | 2.21% |
| Virtus ETF Advisers LLC | 38,260 | $645,000 | 1.77% |
| Cormorant Asset Management, LP | 765,156 | $12,893,000 | 1.54% |
| Rhenman & Partners Asset Management AB | 581,000 | $9,790,000 | 1.48% |
| Granahan Investment Management | 2,082,155 | $35,084,000 | 1.21% |
| BRIDGER MANAGEMENT, LLC | 1,563,862 | $26,351,000 | 0.87% |
| RICE HALL JAMES & ASSOCIATES, LLC | 899,531 | $15,157,000 | 0.87% |